ORIGINAL RESEARCH
Published on 10 Feb 2026
Genomic and immunological differences in endometrial cancer: a comparative study between young and old Asian patients
doi 10.3389/fimmu.2026.1737794
- 387 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Immunological Aspects and Immunotherapy in Gynecologic Cancers
Immunological Aspects and Immunotherapy in Gynecologic Cancers
15k
Total downloads
82k
Total views and downloads
Articles
REVIEW
Published on 09 Feb 2026
Unveiling trends and clinical progress of immunotherapy for endometrial cancer: a scientometric and clinical trial landscape analysis
doi 10.3389/fimmu.2026.1668903
- 522 views
ORIGINAL RESEARCH
Published on 28 Jan 2026
LAG-3–associated CD8+ T-cell dysfunction in the cervical cancer tumor microenvironment
doi 10.3389/fimmu.2026.1750726
- 536 views
ORIGINAL RESEARCH
Accepted on 27 Jan 2026
APOs as promising prognostic biomarkers: correlation with tumor-infiltrating leukocytes in endometrial cancer
- 273 views
ORIGINAL RESEARCH
Published on 21 Jan 2026
Immune-related adverse events and neutrophil-to-lymphocyte ratio as prognostic indicators in gynecologic cancer patients receiving pembrolizumab: a real-world analysis
doi 10.3389/fimmu.2025.1739447
- 988 views
ORIGINAL RESEARCH
Published on 14 Jan 2026
SLC40A1-mediated positive feedback loop with M1 macrophages suppresses epithelial ovarian cancer progression
doi 10.3389/fimmu.2025.1709597
- 1,351 views
ORIGINAL RESEARCH
Published on 09 Jan 2026
The prognostic significance of primary tumor laterality in malignant ovarian teratomas: a 10-year experience at a single institution
doi 10.3389/fimmu.2025.1700779
- 465 views
REVIEW
Published on 09 Jan 2026
Immunotherapy in endometrial cancer: mechanisms, clinical evidence, and future directions
doi 10.3389/fimmu.2025.1697065
- 1,088 views
ORIGINAL RESEARCH
Published on 09 Jan 2026
Cadonilimab rechallenge in patients with recurrent or metastatic cervical cancer following prior PD-1/PD-L1 inhibitor failure: a retrospective multicenter study
doi 10.3389/fimmu.2025.1701319
- 909 views
ORIGINAL RESEARCH
Published on 21 Nov 2025
Soluble immune checkpoints in endometrial cancer – a discovery study
doi 10.3389/fimmu.2025.1721822
- 1,453 views
REVIEW
Published on 20 Nov 2025
Immunological mechanisms and antibody-drug conjugates targeting B7-H3 and B7-H4 in ovarian cancer
doi 10.3389/fimmu.2025.1683674
- 2,481 views
ORIGINAL RESEARCH
Published on 27 Oct 2025
Multi-compartment immune cell profiling highlights the prognostic relevance of CD127+ CD8+ T cells for patients with high-grade serous ovarian cancer
doi 10.3389/fimmu.2025.1607471
- 1,703 views
- 1 citation
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Other participating journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore